Affordable Access

deepdyve-link
Publisher Website

Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods.

Authors
  • Pfaller, Michael A
  • Watanabe, Naoaki
  • Castanheira, Mariana
  • Messer, Shawn A
  • Jones, Ronald N
Type
Published Article
Journal
Journal of Antimicrobial Chemotherapy
Publisher
Oxford University Press
Publication Date
Nov 01, 2011
Volume
66
Issue
11
Pages
2581–2584
Identifiers
DOI: 10.1093/jac/dkr342
PMID: 21873291
Source
Medline
License
Unknown

Abstract

E1210 was found to have potent in vitro activity against Candida spp. when tested by both CLSI and EUCAST BMD methods, with the highest overall EA (97.8%) obtained when E1210 MIC results were read after 24 h of incubation using a partial inhibition EC.

Report this publication

Statistics

Seen <100 times